Showing results (111-120 of 156) with videos related to
Sort By:
Pageof 16
Journal of Controlled Release : Official Journal of the Controlled Release Society|October 14, 2024
The future of genetic medicines delivered via targeted lipid nanoparticles to leukocytesDana Tarab-Ravski, Lior Stotsky-Oterin, Aviad Elisha, et al.Advanced Materials (Deerfield Beach, Fla.)|January 19, 2022
Dual-Targeted Lipid Nanotherapeutic Boost for Chemo-Immunotherapy of CancerSeok-Beom Yong, Srinivas Ramishetti, Meir Goldsmith, et al.Nanoscale|February 27, 2014
Tumor targeting profiling of hyaluronan-coated lipid based-nanoparticlesShoshy Mizrahy, Meir Goldsmith, Shani Leviatan-Ben-Arye, et al.Cancer Letters|May 16, 2015
Serum chemokine network correlates with chemotherapy in non-small cell lung cancerDawei Yang, Jian Zhou, Tao Zeng, et al.Journal of Controlled Release : Official Journal of the Controlled Release Society|July 25, 2021
Therapeutic inhibitory RNA in head and neck cancer via functional targeted lipid nanoparticlesLiyona Kampel, Meir Goldsmith, Srinivas Ramishetti, et al.Nature Microbiology|July 29, 2025
Challenges and opportunities in mRNA vaccine development against bacteriaIlke Aernout, Rein Verbeke, Fabien Thery, et al.Biomaterials|September 15, 2019
Triggered ferroptotic polymer micelles for reversing multidrug resistance to chemotherapyMin Gao, Jian Deng, Fang Liu, et al.Nanoscale|January 7, 2020
An ovarian spheroid based tumor model that represents vascularized tumors and enables the investigation of nanomedicine therapeuticsManu Smriti Singh, Meir Goldsmith, Kavita Thakur, et al.Plos One|August 21, 2012
RNA inhibition highlights cyclin D1 as a potential therapeutic target for mantle cell lymphomaShiri Weinstein, Rafi Emmanuel, Ashley M Jacobi, et al.Pharmaceutics|June 11, 2020
Resveratrol Enhances mRNA and siRNA Lipid Nanoparticles Primary CLL Cell TransfectionEdo Kon, Inbal Hazan-Halevy, Daniel Rosenblum, et al.Pageof 16